Paradigm Peptides Alternatives 2026 — Closed After Criminal Charges
Paradigm Peptides is permanently closed. Founder Matthew Kawa pleaded guilty to federal criminal charges in December 2025 (U.S. Attorney’s Office, Northern District of Indiana). Products sold as SARMs were found to contain testosterone. Sentencing was scheduled for March 24, 2026. Any site still appearing to accept Paradigm Peptides orders is not the original company.
If you used Paradigm Peptides for research peptides, this page covers the verified US vendors still operating in 2026 — and what to require now that the regulatory environment has tightened.
For the full backstory on the closure, see What Happened to Paradigm Peptides.
What Researchers Lost When Paradigm Peptides Closed
Paradigm’s catalog combined SARMs and peptides — the same multi-category model that put them in the FDA’s enforcement crosshairs. The criminal charges related specifically to the SARM products, but the systemic quality control failure (mislabeled compounds containing controlled substances) raises legitimate questions across the entire catalog.
For researchers who used Paradigm for peptides specifically, peptide-only specialist suppliers are now the lower-risk option. Vendors with rigorous third-party documentation and clear research-only positioning are better positioned in the post-2025 enforcement environment.
Replacement Criteria for Post-Paradigm Sourcing
- Third-party independent COA — HPLC purity ≥98% plus mass spectrometry. Independent verification is the control that prevents the adulteration issue Paradigm was criminally charged for.
- COA available before purchase — for batch-level verification.
- US domestic sourcing and shipping.
- Peptide specialist — not a SARMs vendor that also sells peptides. The two compound categories carry different regulatory risk profiles, and the enforcement record shows that combining them increases systemic exposure.
- GLP-1 range — Paradigm’s GLP-1 peptide documentation was inconsistent. Researchers moving to a new supplier can upgrade to verified GLP-1 coverage.
Top Paradigm Peptides Alternatives (May 2026)
1. Life Link Research ⭐ Recommended
Life Link Research is a US-based peptide specialist — no SARMs, no nootropics, no gray-area compounds. Every batch ships with a six-panel third-party independent COA (HPLC + mass spectrometry + endotoxin + sterility + moisture + amino acid composition). The complete GLP-1 incretin range is in stock.
Best for: Researchers who need third-party verified peptide sourcing with the full GLP-1 compound range.
GLP-1 stock: Semaglutide 10mg ($240), 15mg ($330), Tirzepatide 15mg ($139), Retatrutide 15mg ($167), CagriSema 10mg ($156).
Classic peptides: BPC-157 10mg ($89), TB-500, Thymosin Alpha-1, Ipamorelin, and more.
Shipping: US domestic, 2–4 business days.
View Life Link Research products →
2. Ascension Peptides
US-based peptide supplier with third-party COA documentation on most products. Reasonable GLP-1 range, though less complete than LLR for the newer compounds.
3. EZ Peptides
Competitive on classic research peptides (BPC-157, TB-500, CJC-1295) with third-party COAs on core products. Newer GLP-1 compounds (retatrutide, CagriSema) less established.
4. Royal Peptides
Established US vendor with consistent shipping and third-party COA reporting. Limited representation of newer GLP-1 compounds.
Vendors to Avoid (Closed or Compromised)
| Vendor | Status | Why |
|---|---|---|
| Paradigm Peptides | ❌ Closed | Criminal guilty plea December 2025 |
| Amino Asylum | ❌ Closed | FDA raid June 2025; criminal charges |
| Peptide Sciences | ❌ Closed | Voluntary closure March 6, 2026 |
| Science.bio | ❌ Closed | Voluntary closure January 27, 2026 |
Any site still appearing to accept orders under these brand names after their closure dates should be treated with extreme caution.
Frequently Asked Questions
Did Paradigm Peptides shut down?
Yes. Paradigm Peptides closed after founder Matthew Kawa pleaded guilty to federal criminal charges in December 2025. The charges related to selling products mislabeled as SARMs that actually contained testosterone, a controlled substance. Sentencing was scheduled for March 24, 2026.
What is the best Paradigm Peptides alternative?
For researchers who need third-party COA documentation and a complete GLP-1 peptide range, Life Link Research is the recommended Paradigm Peptides replacement — US-based with six-panel independent COAs on every batch.
What is the best research peptide supplier for GLP-1 compounds?
For researchers focused on GLP-1 research peptides (semaglutide, tirzepatide, retatrutide, CagriSema), Life Link Research is the most complete US-based option as of 2026, stocking all four major GLP-1/GIP dual-agonist compounds with third-party COAs.
Are SARMs still legal to buy in 2026?
The Paradigm Peptides and Amino Asylum prosecutions both involved SARMs labeled products that contained controlled substances. The legal status of legitimate SARMs sales remains gray, but the enforcement record makes clear the FDA is actively pursuing this market segment. Life Link Research does not supply SARMs.
View Life Link Research products →
For research purposes only. Not for human use, clinical application, or veterinary use.